Fundraising Fox
Ona Therapeutics
Founded 2019 · 41 employees on LinkedIn · 9 known investors
Find your way into Ona Therapeutics
Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma. The company is a Spanish biotech firm focused on oncology with support from European and Spanish government research funding programs.
Investors · 9
How we know: Asabys Partners's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: Ysios Capital's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$86.6M disclosed across 1 round · 2026
- $86.6MSeries BJun 2026 · 4 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ona Therapeutics do?
- Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma. The company is a Spanish biotech firm focused on oncology with support from European and Spanish government research funding programs.
- Who are Ona Therapeutics's investors?
- Ona Therapeutics's investors include Asabys Partners, Fund+, Korys, Mérieux Equity Partners, Ysios Capital, Alta Life Sciences, Bpifrance, CDTI and 1 more.
- How much funding has Ona Therapeutics raised?
- Ona Therapeutics has disclosed $86.6M raised across 1 round.